NIH Office of Research on Women's Health

Active

Assistance listing
93.313
Agency
Grant awards
Not on record

Program facts

Also known as
(NIH/ORWH)
Treasury account
  • 75-1208-4-6-000

Program details come from SAM.gov Assistance Listings. Updated .

About this program

The National Institutes of Health Office of Research on Women's Health (ORWH), under CFDA 93.313, funds multidisciplinary research projects related to women's health that are identified for support by NIH Institutes and Centers, with the most recent grant opportunity posted July 16, 2026.

The program operates as a co-funding mechanism: ORWH staff review applications submitted by NIH Institutes, Centers, and Offices (ICOs) for administrative relevance to ORWH's mission and program priorities, and the Director makes co-funding decisions based on availability of funds and alignment with both ORWH and the awarding ICO's priorities. Co-funding dollars flow to the administering ICO via Direct CAN Citation, CAN transfer, or Inter-Agency Agreement.

Award eligibility extends to domestic and international nonprofit and for-profit organizations, universities, hospitals, laboratories, state and local government units, and individuals; some initiatives accept foreign organizations. Administrative supplements are not renewable; most other awards run for at least one year. Recipients must retain financial and programmatic records for three years from the date of submission of the annual Financial Status Report to NIH, with extended retention required if litigation, claims, or audits are pending.

Recent grant opportunities span multiple research and training modalities. PA-28-045 (Collaborative Research with NIH Intramural Program, posted July 2026, Cooperative Agreement) seeks translational research partnerships between NIH intramural and extramural investigators to accelerate translation of basic discoveries into clinical applications. PA-27-061 (Research Program Projects, posted February 2026, due May 25, 2029) supports multidisciplinary Program Projects (P01 awards) with at least two research projects and an Administrative Core sharing a common scientific theme. RFA-AI-27-018 (Implementation Science for HIV Prevention, Treatment, and Care, posted November 2025, due June 20, 2029) funds implementation research on strategies to improve uptake and sustainment of evidence-based interventions in communities heavily impacted by HIV. PA-26-001 (Administrative Supplements, posted August 2025, due November 30, 2028) provides supplemental funding to existing NIH grants for unforeseen increased costs within the scope of approved projects.

The program is active and regularly posting opportunities across research, training, and education activity codes.

Objective and description

Objective

ORWH will identify projects on women's health that should be conducted or supported by national research institutes; identify multi-disciplinary research related to research on women 's health that should be conducted or supported; and promote coordi

Description

ORWH will identify projects on women's health that should be conducted or supported by national research institutes; identify multi-disciplinary research related to research on women 's health that should be conducted or supported; and promote coordination and collaboration among entities conducting research.

Eligibility

Applicant eligibility

Awards can be made to domestic, public or private, non-profit or profit organization, university, hospital, laboratory, or other institution including state and local units of government and individuals. Some initiatives will accept applications from foreign organizations. Additional details on eligibility will be specified in the funding opportunity announcement.

Beneficiary eligibility

See information above.

Uses of assistance

To support research and other projects that will accelerate biomedical and behavioral discovery and translation of that knowledge into effective prevention strategies and new treatments.

Length and time phasing of assistance

Almost all awards are made for at least one year. Applicants should review to the specific funding opportunity announcement for further detail.

How to apply

Criteria for selecting proposals

Submitted proposals are accepted for review and possible funding based on the eligibility Information specified in the NOFO.

Award procedure

Applications are reviewed by a peer review group for scientific and technical merit. NIH ICOs submit competitive applications to NIH / OD / DPCPSI /ORWH for potential co-funding by ORWH. ORWH staff perform an administrative review of ICO-submitted applications to for program relevance to the ORWH mission and program priorities. The Director, ORWH makes decisions to co-fund a select set of applications with the awarding ICO. Awards are made based on the availability of funds and the relevance of the proposed project to both ORWH and ICO program priorities. Co-funding dollars are provided to the ICO administering the award using a Direct CAN Citation, CAN transfer, or Inter Agency Agreement, to be applied to the grant award.

Time to approval or disapproval

Applications are reviewed by a peer review group for scientific and technical merit. NIH ICOs submit competitive applications to NIH / OD / DPCPSI /ORWH for potential co-funding by ORWH. ORWH staff perform an administrative review of ICO-submitted applications to for program relevance to the ORWH mission and program priorities.

Renewals

Administrative supplements are not renewable. Other programs may be renewable and applicants must review the funding opportunity announcement for further guidance.

Appeals

A principal investigator may question the substantive or procedural aspects of his/her application by communication with the NIH scientific/research contact as provided in the initiative.

Grant opportunities

Opportunity Status Posted Applications due
Opportunities for Collaborative Research with the NIH Intramural Research Program (U01 Clinical Trial Optional) PAR-28-045 Forecasted —
NIH Research Program Projects (Parent P01 Clinical Trial Optional) PA-27-061 Open
Institutional Mentored Career Development Award (Parent K12) (Clinical Trials Not Allowed) PA-27-030 Open
NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional) PA-26-002 Open
NIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not Allowed) PA-27-036 Open
NIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clinical Trial Not Allowed) PA-27-035 Open
Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional) RFA-AI-27-018 Open
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) PA-26-001 Open
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) PA-27-100 Open
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) PA-27-102 Open
NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional) PA-27-101 Open
Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional) PAR-26-116 Open
NIH Research Education Program - Courses, Curriculum & Methods (Parent R25 - Clinical Trial Not Allowed) PA-27-034 Open
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional) PAR-27-098 Open
NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed) PAR-27-077 Open
NIAMS P30 Centers Program (P30 - Clinical Trial Not Allowed) RFA-AR-28-001 Open
Community Engagement Evaluation and Data Coordination (CEED) Hub to Advance Data and Practice Transformation for Optimizing Oral Health for All (U01, Clinical Trial Not Allowed) RFA-DE-27-001 Closed
Maximizing the Scientific Value of Data Generated by the Environmental influences on Child Health Outcomes (ECHO) Program: Dissertation Grant (R36 - Clinical Trial Not Allowed) RFA-OD-27-006 Closed
Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) RFA-OD-27-008 Open
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) PAR-25-322 Open
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required) PAR-25-323 Closed
Community-Based Participatory Research to Advance Data and Practice Transformation (ADAPT) for Optimizing Oral Health for All (UG3/UH3 Clinical Trial Optional) PAR-27-015 Open
HEAL Initiative: Limited Competition for the HEALthy Brain and Child Development (HBCD) Study - Consortium Administrative Core and Data Coordinating Center (U24 Clinical Trial Not Allowed) RFA-DA-27-014 Closed
NIH Blueprint for Neuroscience: Coordination Center for Interoception Research (BPCCIR) (U24, Clinical Trial Not Allowed) RFA-AT-25-004 Closed
HEAL Initiative: Limited Competition for the HEALthy Brain and Child Development Study - Research Project Sites (Collaborative U01- Clinical Trial Not Allowed) RFA-DA-27-013 Closed
Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trials Not Allowed) RFA-OD-25-003 Open
Intervention Research to Improve Native American Health (R34 Clinical Trial Optional) PAR-25-378 Open
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) PAR-25-379 Open
Limited Competition: Data Analysis and Sharing Center (DASC) for the MACS/WIHS Combined Cohort Study (MWCCS) (U01 Clinical Trials Not Allowed) RFA-HL-26-010 Closed
Limited Competition: Clinical Research Sites (CRS) for the MACS/WIHS Combined Cohort Study (MWCCS) (U01 Clinical Trial Not Allowed) RFA-HL-26-009 Closed
Leadership and Coordination Center (LACC) for the MACS/WIHS Combined Cohort Study (MWCCS) (U01 Clinical Trials Not Allowed) RFA-HL-26-011 Closed
Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required) PAR-25-342 Closed
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) PAR-25-371 Open
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) PAR-25-369 Open
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) PAR-25-370 Open
Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional) PAR-25-354 Closed
Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional) PAR-25-355 Closed
Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed) PAR-25-377 Closed
Limited Competition: Advancing the Science of Complementary and Integrative Health Approaches to Improve Maternal Health Outcomes (R01 Clinical Trial Required) RFA-AT-25-002 Closed
Understanding the Intersection of Social Inequities to Optimize Health and Reduce Health Disparities: The Axes Initiative (R01 Clinical Trial Optional) RFA-NR-25-004 Closed
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed) PAR-25-338 Open
Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional) PAR-25-311 Open
Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional) PAR-25-317 Open
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) PAR-25-296 Open
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional) PAR-25-242 Closed
Research to Address Systemic and Structural Barriers and Facilitators to Improve the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum for People Who Use Substances (R34 Clinical Trials Required) RFA-DA-26-004 Closed
Research to Address Systemic and Structural Barriers and Facilitators to Improve the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum for People Who Use Substances (R01 Clinical Trials Required) RFA-DA-26-003 Closed
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) PAR-25-281 Open
Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional) PAR-25-282 Open
Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) PAS-25-190 Closed
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

Quick answers

What is Assistance Listing 93.313?

Assistance Listing 93.313 is NIH Office of Research on Women's Health, a federal grant program run by National Institutes of Health (Department of Health and Human Services).

What is the CFDA number for NIH Office of Research on Women's Health?

Its CFDA number is 93.313: Assistance Listing numbers were called CFDA numbers before 2018.

Are there open grant opportunities under 93.313?

31 of the latest 50 opportunities under 93.313 are open or forecasted. The latest, Opportunities for Collaborative Research with the NIH Intramural Research Program (U01 Clinical Trial Optional), was posted on July 16, 2026.

On GovTribe

See this program's full record

  • Every grant award and opportunity under it
  • Funding by recipient, agency and assistance type
  • Alerts for new opportunities
  • Ask GovTribe AI about this program